Roche
Yemaachi, Roche Launch African Cancer Atlas Initiative
The companies aim to establish a consortium and build a database of genomics and clinical information from 7,500 African cancer patients.
Foundation Medicine, Sumitomo Pharma to Develop CDx for Acute Leukemia Treatment
The companies will use the FoundationOne Heme platform to identify patients with acute leukemia who have a KMT2A rearrangement or NPM1 mutations.
FDA Approves Roche Antibody Test as CDx for Enhertu in HER2-Ultralow Breast Cancer Patients
The tissue-based test is approved to identify a new classification in HER2 expression designated as HER2-ultralow.
The firm will share new overall survival data from the INAVO120 trial with regulators to support the breast cancer drug's approval.
Researchers aim to validate the AI tool SCORPIO in prospective studies and eventually seek FDA clearance to sell it as a commercial tool in the US.